Label-free and stable serum analysis based on Ag-NPs/PSi surface-enhanced Raman scattering for noninvasive lung...

Surface-enhanced Raman scattering (SERS) has a broad application prospect in the field of tumor detection owing to its ultrahigh detective sensitivity. However, SERS analysis of serum remain a challenge in terms of repeatability and stability due to the maldistribution of the silver nanoparticles (Ag-NPs)-serum. With the aim to make up for this shortcoming, we report a new method for obtaining stable serum Raman signals utilizing the ordered arrays of pyramidal silicon (PSi) and Ag-NPs. We prove the practicability of this method by detecting the samples of serum from 50 lung cancer patients and 50 normal healthy people. Principal component analysis (PCA) of the serum SERS spectra shows that the spectral data of the two sample groups can form obvious and completely separated clusters. The receiver operating characteristic curve provides the sensitivity (100%) and specificity (90%) from the PCA-LDA method. This research indicates that a stable and label-free analysis technique of serum SERS based on Ag-NPs/PSi and PCA-LDA is promising for noninvasive lung cancer diagnoses.